Archive

Filter

Shares of Seres Therapeutics (Nasdaq: MCRB), a research stage biotech company looking to treat gut related diseases by using the body’s own bacteria fell over 60% on July 29 as the company announced disappointing results of its SER-109 Phase II clinical trial against the disease causing gut bacteria Clostridium difficile… Read More

Shares of Cerus Corp. (Nasdaq: CERS) and Rollins Inc. (NYSE: ROL) moved higher on July 29 (and are higher in this morning’s trading) in response to the developing story in the state of Florida with regard to the Zika virus.  Rollins Inc. is the leading global pest control company, operating… Read More

Shares of Seres Therapeutics (Nasdaq: MCRB), a research stage biotech company looking to treat gut related diseases by using the body’s own bacteria,  were down sharply in early trading on July 29 as the company announced disappointing results of its SER-109 clinical trial against the disease causing gut bacteria Clostridium… Read More

Argos Therapeutics (ARGS) announced yesterday evening the terms of its upcoming secondary stock offering, which has sent its share price down more than 15% this morning to partially offset the dilution that will occur after the offering has been completed. The company intends to raise $50 million compared to its… Read More

It’s not often a stock tanks after reporting both an earnings and revenue beat, but that’s exactly what happened to BTP Special Situations Portfolio holding Mobileye (NYSE: MBLY) this morning.In its second quarter earnings report released earlier this morning, Mobileye revealed that revenue shot up 58% year-over-year to $83.5 million. Earnings… Read More

If you own shares of Emergent BioSolutions (NYSE: EBS) you will notice some changes in your portfolio including ownership in shares of a company named Aptevo Therapeutics (Nasdaq: APVO) on August 1. That’s because EBS is spinning off Aptevo, its oncology division. This could create some tax related issues in… Read More

Cancer immunotherapy company ZIOPHARM Oncology (ZIOP) disclosed on July 15th that a patient in one of its brain cancer trial groups died after being treated with its experimental drug treatment, and two other patients also passed away for reasons unrelated to this form of therapy. As we noted… Read More

Artificial intelligence (AI) isn’t just for humiliating chess masters and Jeopardy champions, a la IBM’s Watson supercomputer. AI is already being used widely for routine tasks.Two weeks ago Zendesk (NYSE: ZEN) launched its new Automatic Answers service that answers emails from customers. The system isn’t just an autoresponder, though. It… Read More